- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05735574
Determining Cost of Explant of Neurmodulation Device Due to Infection
To Determine the Cost of Explant and Management of Spinal Cord Stimulation Devices Related to Implantable Pulse Generator Infection in a Single Center Specializing in Neuromodulation
Study Overview
Status
Intervention / Treatment
Detailed Description
Design: Retrospective chart and electronic record review of all explants due to infection with cost analysis up to re-implantation.
Methods:
Based on a database there are approximately N=18-20 infections over 7 years with adequate data to determine the overall cost of explant due to infection. The data to be collected will include: hospital admission, surgical time, blood tests, swabs, antibiotic therapy, additional outpatient visits, cost of re-implantation. These can be collected from electronic patient records (EPR). The cost of individual patient admissions will be obtained from the account services at Guys and St Thomas's and sent in a password protected database.
The site of infection will also be recorded and this can be obtained from the operative note. A study by Hayek and colleagues have indicated only 10% of infections are at the lead site and the majority are at the IPG site. Another review by Follet and colleagues have indicated only 54% of infections are at the IPG site, 17% at the lead site and the others not clearly determined. For this reason, there will need to be a range of costs based on the confirmed and the indeterminate sites of infection. The main focus of this paper will be on IPG infections since TYRX is only used at the IPG site.
Economic metrics will also be taken into consideration which have been described in the UK as some patients for technical reasons cannot be re-implanted with SCS systems after infection. The cost effectiveness of this therapy is essentially lost in these patients forever. The time proceeding to re-implantation can also be reviewed and incorporated. There was an NIHR review of cost analysis of these systems published in the UK that can be used for this. Specifically the cost of SCS and conventional medical management (CMM) is £3440 in year one of these devices and CMM alone is £6936.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Jonathan Royds, MB MD
- Phone Number: switch +44 20 7188 7188
- Email: jonathan.royds@gstt.nhs.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any patient who had an explant of a neuromodulation device due to infection between 2013-2020 in our centre.
- Any patient who had as suspected explant of a spinal cord stimulator due to infection
Exclusion Criteria:
• Explant of a device for another reason
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost of explant, intermediate care and re-implantation of device
Time Frame: Until device re-implanted which will vary from 3 months- 1 year
|
Cost of explant, intermediate care and re-implantation of device
|
Until device re-implanted which will vary from 3 months- 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pathway of patients from device explantation until re-implantation of device
Time Frame: up to re-implant or decision not to which will vary from 3 month- 1 year
|
up to re-implant or decision not to which will vary from 3 month- 1 year
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 307575
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections
-
International Centre for Diarrhoeal Disease Research...Centers for Disease Control and PreventionNot yet recruitingMeasles | Rubella | Cholera | Typhoid
-
MJM BontenJanssen Research & Development, LLC; Innovative Medicines InitiativeCompletedE.Coli InfectionsUnited States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
-
PfizerCompletedGroup B Streptococcus InfectionsUnited States, South Africa, United Kingdom
-
GlaxoSmithKlineActive, not recruitingInfections, MeningococcalFinland, Poland, Spain, United Kingdom, Germany, South Africa, Dominican Republic, Israel, Honduras
-
PfizerCompletedInfections, MeningococcalAustralia, Canada, Czechia, Panama, South Africa, Turkey
-
GlaxoSmithKlineCompletedInfections, MeningococcalFinland
-
PfizerCompletedInfections, MeningococcalPhilippines
-
GlaxoSmithKlineCompletedInfections, MeningococcalUnited States, Finland, Poland
-
GlaxoSmithKlineCompleted
Clinical Trials on IPG infections
-
Pablo López PaisRecruitingFailed Back Surgery Syndrome | Spinal Cord StimulationSpain
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Medtronic Bakken Research CenterMedtronicCompleted
-
Abbott Medical DevicesCompleted
-
Dennis Turner, M.D.National Institute of Neurological Disorders and Stroke (NINDS); National Institutes...Completed
-
Abbott Medical DevicesCompleted
-
Imperial College LondonCompletedRNA Virus Infections | Respiratory Tract Infections | Covid19 | Influenza | Infection, Bacterial | SARS (Severe Acute Respiratory Syndrome) | Respiratory Viral Infection | Infection ViralUnited Kingdom
-
Abbott Medical DevicesCompletedChronic Pain | Intractable PainSpain, Canada, United States, Finland, Germany, Italy, Switzerland
-
Hospices Civils de LyonCompletedRate of Infections | Operating Site | Post-operative Surgery | Bone Flap Surgery | OtolaryngologyFrance
-
NewronikaNot yet recruiting